Lowey Dannenberg, P.C. is Investigating The Bancorp, Inc. (“TBBK” or the “Company”) (NASDAQ:TBBK) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
May 07, 2024 12:16 ET
|
Lowey Dannenberg, P.C.
NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Bancorp, Inc. (“TBBK” or the “Company”)...
Lowey Dannenberg, P.C. is Investigating The Bancorp, Inc. (“TBBK” or the “Company”) (NASDAQ:TBBK) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
May 03, 2024 11:50 ET
|
Lowey Dannenberg, P.C.
NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Bancorp, Inc. (“TBBK” or the “Company”)...
Lowey Dannenberg, P.C. is Investigating The Bancorp, Inc. (“TBBK” or the “Company”) (NASDAQ:TBBK) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 22, 2024 10:29 ET
|
Lowey Dannenberg, P.C.
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Bancorp, Inc. (“TBBK” or the...
Lowey Dannenberg, P.C. is Investigating The Bancorp, Inc. (“TBBK” or the “Company”) (NASDAQ:TBBK) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 19, 2024 10:17 ET
|
Lowey Dannenberg, P.C.
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Bancorp, Inc. (“TBBK” or the...
Lowey Dannenberg, P.C. is Investigating The Bancorp, Inc. (“TBBK” or the “Company”) (NASDAQ:TBBK) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 15, 2024 11:10 ET
|
Lowey Dannenberg, P.C.
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Bancorp, Inc. (“TBBK” or the...
Lowey Dannenberg, P.C. is Investigating The Bancorp, Inc. (“TBBK” or the “Company”) (NASDAQ:TBBK) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 11, 2024 15:37 ET
|
Lowey Dannenberg, P.C.
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Bancorp, Inc. (“TBBK” or the...
South Korea-Based Luxury Second-hand Platform, EPIC Corporation with $17 million annual revenue, gears up for global app launch
March 13, 2024 00:44 ET
|
Epic Corporation
SEOUL, South Korea, March 13, 2024 (GLOBE NEWSWIRE) -- Epic Corporation operates Epic One, a luxury secondhand trading platform based in South Korea. The company achieved an annual revenue of $17...
Dayton Children's Hospital Bridges Epic Hyperdrive Migration with PortalGuard® IAM Cloud to Expand its Utilization of BIO-key Identity-Bound Biometrics
April 11, 2023 07:57 ET
|
BIO-key International, Inc.
DAYTON, Ohio and WALL, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM)...
EPIC Strives to Be the Most Decentralized Cryptocurrency Network
March 22, 2023 08:52 ET
|
EPIC
NEW YORK, NY, March 22, 2023 (GLOBE NEWSWIRE) -- EPIC announces further improvement of its technology, aiming to become the most decentralized cryptocurrency network. In the original Bitcoin design,...
invIOs to present at upcoming industry and investor conferences
October 11, 2022 02:00 ET
|
invIOs GmbH
VIENNA, Austria, Oct. 11, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, today announces its participation at three...